Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse/Recurrence”

6,989 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,989 results

Testing effectiveness (Phase 2)WithdrawnNCT05170789
What this trial is testing

Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Tulane University School of Medicine
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Not applicableLooking for participantsNCT06474403
What this trial is testing

Laparoscopic Total Extraperitoneal Plasty as a Modification of Sugabecker's Operation

Who this might be right for
Parastomal Hernia
State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital 50
Early research (Phase 1)Looking for participantsNCT02203903
What this trial is testing

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Who this might be right for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Catherine Bollard 50
Not applicableStudy completedNCT03977870
What this trial is testing

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis

Who this might be right for
Venous Thromboembolism (VTE)
Assistance Publique Hopitaux De Marseille 843
Testing effectiveness (Phase 2)WithdrawnNCT00005969
What this trial is testing

Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center
Not applicableUnknownNCT04145973
What this trial is testing

Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 200
Early research (Phase 1)WithdrawnNCT02105350
What this trial is testing

MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

Who this might be right for
Biliary Tract CarcinomaGallbladder Carcinoma
University Health Network, Toronto
Testing effectiveness (Phase 2)Looking for participantsNCT07140679
What this trial is testing

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Who this might be right for
Localized Colon CarcinomaStage IIB Colon Cancer AJCC v8Stage IIC Colon Cancer AJCC v8+1 more
Emory University 40
Testing effectiveness (Phase 2)Study completedNCT00587626
What this trial is testing

Proposal to Evaluate the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder Pain

Who this might be right for
Neck PainShoulder PainCervical Pain
Hamilton Health Sciences Corporation 80
Early research (Phase 1)UnknownNCT05474885
What this trial is testing

BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
iCell Gene Therapeutics 15
Early research (Phase 1)WithdrawnNCT03605589
What this trial is testing

Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma

Who this might be right for
Leukemia, B-cellLymphoma, B-Cell
Children's Hospital Medical Center, Cincinnati
Testing effectiveness (Phase 2)Looking for participantsNCT07341191
What this trial is testing

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Who this might be right for
Mantle Cell Lymphoma
Canadian Cancer Trials Group 40
Not applicableUnknownNCT04266327
What this trial is testing

RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph Nodes

Who this might be right for
BrachytherapySquamous Cell Carcinomas
Peking University Third Hospital 30
Not applicableUnknownNCT01848015
What this trial is testing

Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 200
Not applicableUnknownNCT06627010
What this trial is testing

Herpes Simplex Meningo Encephalitis Recurrence

Who this might be right for
Herpes Simplex Meningo Encephalitis
Central Hospital, Nancy, France 30
Not applicableLooking for participantsNCT05965024
What this trial is testing

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 377
Not applicableStudy completedNCT02171078
What this trial is testing

Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance

Who this might be right for
Breast Neoplasms
University of Wisconsin, Madison 34,359
Testing effectiveness (Phase 2)Looking for participantsNCT05996185
What this trial is testing

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Who this might be right for
T Cell LymphomaT-cell Lymphoma
Yale University 22
Testing effectiveness (Phase 2)Study completedNCT00231855
What this trial is testing

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

Who this might be right for
Ovarian NeoplasmsUterine Neoplasms
Montefiore Medical Center 31
Load More Results